GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Evaxion AS (NAS:EVAX) » Definitions » Accumulated other comprehensive income (loss)

EVAX (Evaxion AS) Accumulated other comprehensive income (loss) : $-3.60 Mil (As of Dec. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Evaxion AS Accumulated other comprehensive income (loss)?

Accumulated other comprehensive income (loss) is the aggregate amount of gains or losses that are not part of retained earnings. Evaxion AS's Accumulated other comprehensive income (loss) for the quarter that ended in Dec. 2024 was $-3.60 Mil.

Evaxion AS's quarterly Accumulated other comprehensive income (loss) declined from Jun. 2024 ($105.98 Mil) to Sep. 2024 ($0.00 Mil) and declined from Sep. 2024 ($0.00 Mil) to Dec. 2024 ($-3.60 Mil).

Evaxion AS's annual Accumulated other comprehensive income (loss) declined from Dec. 2022 ($-3.65 Mil) to Dec. 2023 ($-3.77 Mil) but then increased from Dec. 2023 ($-3.77 Mil) to Dec. 2024 ($-3.60 Mil).

Evaxion AS Accumulated other comprehensive income (loss) Historical Data

The historical data trend for Evaxion AS's Accumulated other comprehensive income (loss) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Evaxion AS Accumulated other comprehensive income (loss) Chart

Evaxion AS Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Accumulated other comprehensive income (loss)
Get a 7-Day Free Trial 31.67 -1.32 -3.65 -3.77 -3.60

Evaxion AS Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Accumulated other comprehensive income (loss) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -3.77 - 105.98 - -3.60

Evaxion AS Accumulated other comprehensive income (loss) Calculation

Accumulated other comprehensive income (loss) is the aggregate amount of gains or losses that are not part of retained earnings.

Evaxion AS Accumulated other comprehensive income (loss) Related Terms

Thank you for viewing the detailed overview of Evaxion AS's Accumulated other comprehensive income (loss) provided by GuruFocus.com. Please click on the following links to see related term pages.

Evaxion AS Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Evaxion AS (NAS:EVAX) » Definitions » Accumulated other comprehensive income (loss)
Comparable Companies
DWTX INTI HOOK BTAI SNSE ICU PHIO ATHA KPRX HOTH VRTX ASX:CSL REGN XKRX:207940 XBRU:ARGX ALNY XBRU:UCB ONC BNTX XKRX:068270
Traded in Other Exchanges
N/A
Address
Dr. Neergaards Vej 5f, Hoersholm, DNK, 2970
Website
https://www.evaxion.ai
Evaxion Biotech AS is a clinical-stage biotech company that aspires to the exploration of artificial intelligence, or AI, to develop immunotherapies with improved efficacy when compared to currently marketed products for patients with unmet medical needs. Its pipeline programs are derived from its proprietary AI platforms, PIONEER, EDEN, RAVEN, and ObsERV. The company is utilizing these AI platforms to build a drug development pipeline. Its product candidates are: EVX-01, EVX-03, and EVX-02, which are vaccine candidates being developed for the treatment of various solid cancers. In addition, the company is developing EVX-B1, EVX-B2, EVX-B3, EVX-V1, and multiple other vaccine candidates for various infectious diseases, such as cytomegalovirus, N.gonorrhoeae, bacterial pathogens, and others.